Precipio, Inc. – NASDAQ:PRPO
Precipio stock price today
Precipio stock price monthly change
Precipio stock price quarterly change
Precipio stock price yearly change
Precipio key metrics
Market Cap | 7.81M |
Enterprise value | 12.50M |
P/E | -1.23 |
EV/Sales | 0.94 |
EV/EBITDA | -0.75 |
Price/Sales | 1.10 |
Price/Book | 0.89 |
PEG ratio | 0.03 |
EPS | -3.73 |
Revenue | 15.03M |
EBITDA | -5.53M |
Income | -4.90M |
Revenue Q/Q | 21.83% |
Revenue Y/Y | 53.67% |
Profit margin | -143.2% |
Oper. margin | -151.54% |
Gross margin | 30.14% |
EBIT margin | -151.54% |
EBITDA margin | -36.85% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePrecipio stock price history
Precipio stock forecast
Precipio financial statements
| Jun 2023 | 3.53M | -2.29M | -64.9% |
|---|---|---|---|
| Sep 2023 | 3.73M | -1.45M | -38.92% |
| Dec 2023 | 4.32M | 925K | 21.37% |
| Mar 2024 | 3.43M | -2.07M | -60.58% |
| 2025 | 64.91M | 21.28M | 32.79% |
|---|---|---|---|
| 2026 | 80.25M | 35.56M | 44.31% |
Analysts Price target
Financials & Ratios estimates
| 2023-03-29 | -0.06039 | -0.09 |
|---|
| Jun 2023 | 19472000 | 5.38M | 27.63% |
|---|---|---|---|
| Sep 2023 | 19053000 | 6.05M | 31.76% |
| Dec 2023 | 18101000 | 3.67M | 20.29% |
| Mar 2024 | 16623999 | 3.85M | 23.16% |
| Jun 2023 | -1.20M | -32K | 1.66M |
|---|---|---|---|
| Sep 2023 | -896K | -23K | -92K |
| Dec 2023 | 114K | -49K | -125K |
| Mar 2024 | -667K | 0 | -59K |
Precipio alternative data
| Aug 2023 | 53 |
|---|---|
| Sep 2023 | 53 |
| Oct 2023 | 53 |
| Nov 2023 | 53 |
| Dec 2023 | 53 |
| Jan 2024 | 53 |
| Feb 2024 | 53 |
| Mar 2024 | 53 |
| Apr 2024 | 53 |
| May 2024 | 51 |
| Jun 2024 | 51 |
| Jul 2024 | 51 |
Precipio other data
| Period | Buy | Sel |
|---|---|---|
| Nov 2024 | 0 | 2000 |
| Dec 2024 | 30000 | 24000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | SANDBERG RICHARD A director | Common Stock | 30,000 | $5.95 | $178,440 | ||
Sale | SANDBERG RICHARD A director | Common Stock | 24,000 | $6.04 | $144,912 | ||
Sale | SANDBERG RICHARD A director | Common Stock | 2,000 | $6.28 | $12,558 | ||
Purchase | SANDBERG RICHARD A director | Common Stock | 20,000 | $0.78 | $15,540 | ||
Purchase | DANIELI ILAN director, officer.. | Common Stock | 16,500 | $0.6 | $9,851 | ||
Purchase | SABET AHMED ZAKI officer: Chief Op.. | Common Stock | 750 | $0.6 | $448 | ||
Purchase | SANDBERG RICHARD A director | Common Stock | 20,000 | $0.55 | $11,060 | ||
Purchase | DANIELI ILAN director, officer.. | Common Stock | 11,000 | $0.87 | $9,570 | ||
Purchase | SABET AHMED ZAKI officer: Chief Op.. | Common Stock | 500 | $0.87 | $435 | ||
Purchase | DANIELI ILAN director, officer.. | Common Stock | 3,268 | $1.55 | $5,062 |
| Patent |
|---|
Application Filling date: 12 Jun 2019 Issue date: 19 Dec 2019 |
| Quarter | Transcript |
|---|---|
| Q3 2023 20 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 17 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 18 May 2023 | Q1 2023 Earnings Call Transcript |
| Q4 2022 3 Apr 2023 | Q4 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Ilan Danieli (1972) Founder, Pres, Chief Executive Officer & Director | $334,890 |
| Mr. Carl R. Iberger (1953) Chief Financial Officer & Sec. | $302,580 |
Mr. Ayman Mohamed M.D. (1986) Senior Vice President of R&D and Laboratory Operations | $192,110 |
| Mr. Ahmed Zaki Sabet (1987) Chief Operating Officer | $168,790 |
-
What's the price of Precipio stock today?
One share of Precipio stock can currently be purchased for approximately $14.3.
-
When is Precipio's next earnings date?
Unfortunately, Precipio's (PRPO) next earnings date is currently unknown.
-
Does Precipio pay dividends?
No, Precipio does not pay dividends.
-
How much money does Precipio make?
Precipio has a market capitalization of 7.81M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 61.46% to 15.2M US dollars. Precipio made a loss 5.85M US dollars in net income (profit) last year or -$0.09 on an earnings per share basis.
-
What is Precipio's stock symbol?
Precipio, Inc. is traded on the NASDAQ under the ticker symbol "PRPO".
-
What is Precipio's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Precipio?
Shares of Precipio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Precipio's key executives?
Precipio's management team includes the following people:
- Mr. Ilan Danieli Founder, Pres, Chief Executive Officer & Director(age: 53, pay: $334,890)
- Mr. Carl R. Iberger Chief Financial Officer & Sec.(age: 72, pay: $302,580)
- Mr. Ayman Mohamed M.D. Senior Vice President of R&D and Laboratory Operations(age: 39, pay: $192,110)
- Mr. Ahmed Zaki Sabet Chief Operating Officer(age: 38, pay: $168,790)
-
Is Precipio founder-led company?
Yes, Precipio is a company led by its founder Mr. Ilan Danieli.
-
How many employees does Precipio have?
As Jul 2024, Precipio employs 51 workers, which is 4% less then previous quarter.
-
When Precipio went public?
Precipio, Inc. is publicly traded company for more then 8 years since IPO on 30 Jun 2017.
-
What is Precipio's official website?
The official website for Precipio is precipiodx.com.
-
Where are Precipio's headquarters?
Precipio is headquartered at 4 Science Park, New Haven, CT.
-
How can i contact Precipio?
Precipio's mailing address is 4 Science Park, New Haven, CT and company can be reached via phone at +20 3 7877888.
Precipio company profile:
Precipio, Inc.
precipiodx.comNASDAQ
51
Medical - Diagnostics & Research
Healthcare
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
New Haven, CT 06511
CIK: 0001043961
ISIN: US74019L6020
CUSIP: 74019L503
